PDE5A and erectile dysfunction: Some studies have demonstrated that the PDE5 inhibitor sildenafil which is clinically used for treating erectile dysfunction diseases, promotes melanoma cell invasion and growth and increases melanoma risk (Arozarena et al., 2011; Li et al., 2014).